 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
||
O seu fornecedor confiável de medicamentos genéricos.
|
||||||||||||
Lista de Categorias
AlcoolismoAlzheimer E ParkinsonAnalgésicosAnti-InflamatóriosAnti-helmínticosAnti-viraisAntialérgicosAntibióticosAnticoncepcionaisAnticonvulsivantesAntidepressivosAntifúngicosArtriteAsmaCancroCirúrgiaColesterolCuidados Da PeleCuidados Para Los OjosDiabetesDisfunção EréctilDiuréticosDoenças CardiovascularesEnxaquecasH I VHipertensão ArterialObesidadeOsteoporosePerturbações MentaisPerturbações NeurológicasRelaxantes MuscularesSaúde FemininaSaúde MasculinaTrato GastrointestinalTrato RespiratórioTrato Urinário
10 May 2012 22:35:04
Whistleblower suit claiming pioglitazone cover-up implicates Nissen, Cleveland ...
Whistleblower suit claiming pioglitazone cover-up implicates Nissen, Cleveland ... TheHeart.Org Ge's suit names only the pharmaceutical company as defendant but does allege that financial connections between the Cleveland Clinic's Dr Steven Nissen "should be considered when analyzing Actos's risks compared with Avandia's .
08 May 2012 19:05:06
Suspicious Link Between Actos and Doctor Raises Safety Concerns
Suspicious Link Between Actos and Doctor Raises Safety Concerns DrugWatch.com When Dr. Steve Nissen, one of the top cardiologists in the country, heralded the death knell for Avandia by finding the diabetes drug increased the risk of heart attack and found that its competitor Actos lowered the risk, the good doctor was hailed as ...
07 May 2012 20:43:36
Abbott Settles Marketing Lawsuit
USA TODAY Abbott Settles Marketing Lawsuit New York Times Last year, GlaxoSmithKline, the British drug company, agreed to pay $3 billion to settle civil and criminal investigations into its sales practices for several drugs, including the diabetes drug Avandia . In 2009, Pfizer paid $2.3 billion to settle ... Abbott Laboratories agrees to $1.6 billion settlement over marketing of Depakote Abbott Labs agrees to pay $1.6 billion to settle Depakote cases07 May 2012 14:49:07
5 Questions: Goodman on recommendations to help FDA detect drug risks earlier
5 Questions: Goodman on recommendations to help FDA detect drug risks earlier Medical Xpress The unexpected harms that people have suffered in recent years from taking the antidiabetes drug Avandia , the pain-reliever Vioxx and the cholesterol-reducing drug Crestor have underscored the need for improvements. A report released today by a ...
03 May 2012 23:44:02
FDA Must be Proactive About Postapproval Drug Safety: IOM
ClaimsJournal.com FDA Must be Proactive About Postapproval Drug Safety: IOM Medscape This report was prompted by several high-profile drugs found to be harmful once they were in widespread use, including Vioxx (rofecoxib, Merck), Avandia (rosiglitazone, GlaxoSmithKline), and selective serotonin reuptake inhibitors (in children). IOM report recommends US expand drug safety monitoring after approval Better Ways Needed to Track Drug Safety: Report03 May 2012 16:06:08
Avandia Sales Slumped on Heart Risks: Adverse Events
Avandia Sales Slumped on Heart Risks: Adverse Events Albany Times Union On April 25th, 2012, Reuters reported that Avandia sales are collapsing as the drug has been linked to heart risks. Avandia , a popular drug manufactured by GlaxoSmithKline, was first approved by the FDA in 1999 to treat Type 2 diabetes in adult ...
30 Apr 2012 23:12:36
Double-drug diabetes treatment disappoints in kids
CBS News Double-drug diabetes treatment disappoints in kids Chicago Tribune Within a year, on average, half of kids on metformin and some 40 percent taking both metformin and rosiglitazone ( Avandia ) ended up having to resort to insulin injections to control their blood sugar, researchers reported Sunday at the annual meeting ... Overweight teens have trouble managing Type 2 diabetes; many fail to keep ... Childhood Diabetes: Kids Face Lifetime of Illness Type 2 Diabetes Is Tougher to Treat in Kids and Teens29 Apr 2012 23:02:25
Two-Drug Therapy Helped Kids With Type 2 Diabetes
CBS News Two-Drug Therapy Helped Kids With Type 2 Diabetes U.S. News & World Report By Steven Reinberg SUNDAY, April 29 (HealthDay News) -- Children with type 2 diabetes may achieve better blood sugar control with a combination of two drugs, metformin and Avandia , than with metformin alone, a new study suggests. Double-drug diabetes treatment disappoints in kids Type 2 Diabetes in Kids a Challenge to Control Newly Diagnosed Teens Have Trouble Managing Diabetes, Study Says - -product avandia is not found!
Sorry we do not carry avandia at this time.
- You can try to search avandia in our product database - CLICK HERE TO SEARCH.
- Fill in the product request form and we will add the requested medicine shortly - PRODUCT REQUEST FORM
Choose Your language:
Pesquisa no site:
TestemunhosNovidadesArtigo
Olá, obrigado,
a encomenda chegou a semana passada, sem problemas, o efeito... bem, estou muito ocupado agora com minhas namoradas.
- Steve
- Pregnancy-related diabetes: reducing the risk of complications
If you’re pregnant, it can be worrying to find out you have developed diabetes.
- Weight training and aerobic exercise can help control diabetes
If you have type 2 diabetes, weight training can help control your blood glucose levels, as can aerobic exercise such as jogging or cycling, according to a new study.
- Vital steps to combat a big problem
There are many reasons why schoolchildren are becoming fatter, less fit and less active: most are driven to school; they eat more junk food, consuming ever more fat, salt and sugar; parental fear means many young people stay indoors, and they devote more hours to watching TV and playing computer games than to playing sport.
 |
Adicionar este sítio aos Favoritos |
|---|
